Literature DB >> 16951733

The need for speed: an update on methamphetamine addiction.

Alasdair M Barr1, William J Panenka, G William MacEwan, Allen E Thornton, Donna J Lang, William G Honer, Tania Lecomte.   

Abstract

The psychostimulant methamphetamine (MA) is a highly addictive drug that has surged in popularity over the last decade in North America. A burgeoning number of clandestine drug laboratories has led to dramatic increases in MA production, which have resulted in significant public health, legal and environmental problems. Current evidence indicates that exposure to MA is neurotoxic, and neuroimaging studies confirm that long-term use in humans may lead to extensive neural damage. These physiological changes are commonly associated with persistent forms of cognitive impairment, including deficits in attention, memory and executive function. In the present review, we provide a comprehensive description of the factors relating to MA use and the major health-related consequences, with an emphasis on MA-induced psychosis. It is hoped that increased knowledge of MA abuse will provide the basis for future treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951733      PMCID: PMC1557685     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  145 in total

1.  Abnormal cerebral perfusion in chronic methamphetamine abusers: a study using 99MTc-HMPAO and SPECT.

Authors:  M Iyo; H Namba; M Yanagisawa; S Hirai; N Yui; S Fukui
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1997-07       Impact factor: 5.067

2.  Tolerance to the anhedonic effects of lipopolysaccharide is associated with changes in syntaxin immunoreactivity in the nucleus accumbens.

Authors:  Alasdair M Barr; Cai Song; Ken Sawada; Clint E Young; William G Honer; Anthony G Phillips
Journal:  Int J Neuropsychopharmacol       Date:  2003-03       Impact factor: 5.176

Review 3.  Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

Authors:  John Grabowski; James Shearer; John Merrill; S Stevens Negus
Journal:  Addict Behav       Date:  2004-09       Impact factor: 3.913

Review 4.  The role of the dopamine transporter in cocaine abuse.

Authors:  Sari Izenwasser
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

5.  Shape changes of the corpus callosum in abstinent methamphetamine users.

Authors:  Jungsu S Oh; In Kyoon Lyoo; Young Hoon Sung; Jaeuk Hwang; Jihyun Kim; Ain Chung; Kwang Suk Park; Seog Ju Kim; Perry F Renshaw; In Chan Song
Journal:  Neurosci Lett       Date:  2005 Aug 12-19       Impact factor: 3.046

6.  Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M J Sedler; S J Gatley; R Hitzemann; Y S Ding; C Wong; J Logan
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

7.  Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity.

Authors:  J Yuan; B T Callahan; U D McCann; G A Ricaurte
Journal:  J Neurochem       Date:  2001-06       Impact factor: 5.372

8.  Exposure to repeated, intermittent d-amphetamine induces sensitization of HPA axis to a subsequent stressor.

Authors:  Alasdair M Barr; Candace E Hofmann; Joanne Weinberg; Anthony G Phillips
Journal:  Neuropsychopharmacology       Date:  2002-03       Impact factor: 7.853

9.  Abuse and violence history of men and women in treatment for methamphetamine dependence.

Authors:  Judith B Cohen; Alice Dickow; Kathryn Horner; Joan E Zweben; Joseph Balabis; Denna Vandersloot; Chris Reiber
Journal:  Am J Addict       Date:  2003 Oct-Dec

10.  Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers.

Authors:  G A Ricaurte; L S Seiden; C R Schuster
Journal:  Brain Res       Date:  1984-06-15       Impact factor: 3.252

View more
  152 in total

1.  Characteristics of Asian and Pacific Islanders admitted to U.S. drug treatment programs in 2005.

Authors:  Wynnie Wong; Paul G Barnett
Journal:  Public Health Rep       Date:  2010 Mar-Apr       Impact factor: 2.792

2.  Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations.

Authors:  Lisa M McFadden; Madison M Hunt; Paula L Vieira-Brock; Janice Muehle; Shannon M Nielsen; Scott C Allen; Glen R Hanson; Annette E Fleckenstein
Journal:  Drug Alcohol Depend       Date:  2012-05-28       Impact factor: 4.492

3.  Risk Behaviors Among Suburban Women who Use Methamphetamine: Social Harms and Social Solutions.

Authors:  Aukje Lamonica; Miriam Boeri
Journal:  J Appl Soc Sci (Boulder)       Date:  2015-09-01

4.  A stress steroid triggers anxiety via increased expression of α4βδ GABAA receptors in methamphetamine dependence.

Authors:  H Shen; A Mohammad; J Ramroop; S S Smith
Journal:  Neuroscience       Date:  2013-08-29       Impact factor: 3.590

5.  A longitudinal study of self-reported psychopathology in early ecstasy and amphetamine users.

Authors:  Daniel Wagner; Philip Koester; Benjamin Becker; Euphrosyne Gouzoulis-Mayfrank; Martin Hellmich; Joerg Daumann
Journal:  Psychopharmacology (Berl)       Date:  2014-08-27       Impact factor: 4.530

6.  Elevated neurobehavioral symptoms are associated with everyday functioning problems in chronic methamphetamine users.

Authors:  Jordan E Cattie; Steven Paul Woods; Jennifer E Iudicello; Carolina Posada; Igor Grant
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

7.  Age-dependent effects of neonatal methamphetamine exposure on spatial learning.

Authors:  Charles V Vorhees; Matthew R Skelton; Michael T Williams
Journal:  Behav Pharmacol       Date:  2007-09       Impact factor: 2.293

8.  Chlorophenylpiperazine analogues as high affinity dopamine transporter ligands.

Authors:  William C Motel; Jason R Healy; Eddy Viard; Buddy Pouw; Kelly Martin; Rae R Matsumoto; Andrew Coop
Journal:  Bioorg Med Chem Lett       Date:  2013-10-15       Impact factor: 2.823

9.  Methamphetamine-induced psychosis is associated with DNA hypomethylation and increased expression of AKT1 and key dopaminergic genes.

Authors:  Shabnam Nohesara; Mohammad Ghadirivasfi; Mahmood Barati; Mohammad-Reza Ghasemzadeh; Samira Narimani; Zohreh Mousavi-Behbahani; Mohammadtaghi Joghataei; Mansoureh Soleimani; Mozhgan Taban; Soraya Mehrabi; Sam Thiagalingam; Hamid Mostafavi Abdolmaleky
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-10-18       Impact factor: 3.568

10.  PET studies of d-methamphetamine pharmacokinetics in primates: comparison with l-methamphetamine and ( --)-cocaine.

Authors:  Joanna S Fowler; Carsten Kroll; Richard Ferrieri; David Alexoff; Jean Logan; Stephen L Dewey; Wynne Schiffer; David Schlyer; Pauline Carter; Payton King; Colleen Shea; Youwen Xu; Lisa Muench; Helene Benveniste; Paul Vaska; Nora D Volkow
Journal:  J Nucl Med       Date:  2007-09-14       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.